News

Filter

1 to 9 of 10 results

Lumara Health to be acquired in two separate deals for up to $1.107 billion

Lumara Health to be acquired in two separate deals for up to $1.107 billion

29-09-2014

Closely-held USA-based Lumara Health (previously K-V Pharmaceutical) today announced that it has entered…

AMAG PharmaceuticalsClindesseEvamistGynazoleLumara HealthMakenaMergers & AcquisitionsPerrigoPharmaceuticalUSAWomen's Health

FDA cites insufficient information in response to AMAG’s Feraheme application

FDA cites insufficient information in response to AMAG’s Feraheme application

23-01-2014

US drug company AMAG Pharmaceuticals (Nasdaq: AMAG) has received a complete response letter from the…

AMAG PharmaceuticalsFerahemeHematologyNephrology and HepatologyPharmaceuticalRegulationUSA

Licensing deals between Xenon and Isis for XEN701, and Access and AMAG for MuGard

10-06-2013

USA-based Isis Pharmaceuticals (Nasdaq: ISIS) revealed that privately-held Canadian firm Xenon Pharmaceuticals…

Access PharmaceuticalsAMAG PharmaceuticalsIsis PharmaceuticalsLicensingMuGardNephrology and HepatologyOncologyPharmaceuticalXEN701Xenon Pharmaceuticals

Rainbow Coral seeks place in $84.6 billion biotechnology sector, forming new division; AMAG merger with Allos called off

23-10-2011

Florida, USA-based Rainbow Coral (OTCQB: RBCC) last week announced its intention to move into the discovery…

Allos TherapeuticsAMAG PharmaceuticalsBiotechnologyMergers & AcquisitionsPharmaceuticalRainbow BiosciencesResearch

Allos looks to complete merger with AMAG, as third party bows out

11-10-2011

Allos Therapeutics (Nasdaq: ALTH) says that it continues to work with fellow USA-based AMAG Pharmaceuticals…

Allos TherapeuticsAMAG PharmaceuticalsMergers & AcquisitionsPharmaceutical

US deal for Vectura; takeover bid for AMAG

03-08-2011

There was good news this morning from Vectura Group (LSE: VEC), a UK-based inhalation product development…

Allos TherapeuticsAMAG PharmaceuticalsLicensingMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryVectura

AMAG Pharma and Allos Thera to merge in $686 million stock deal; Express Scripts to buy Medco

21-07-2011

US drugmakers AMAG Pharmaceuticals (Nasdaq: AMAG) and Allos Therapeutics (Nasdaq: ALTH) entered into…

Allos TherapeuticsAMAG PharmaceuticalsBiotechnologyMergers & AcquisitionsPharmaceutical

1 to 9 of 10 results

COMPANY SPOTLIGHT

Menarini

Back to top